» Articles » PMID: 16008818

Return of the Cycad Hypothesis - Does the Amyotrophic Lateral Sclerosis/parkinsonism Dementia Complex (ALS/PDC) of Guam Have New Implications for Global Health?

Overview
Specialty Neurology
Date 2005 Jul 13
PMID 16008818
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Recently published work provides evidence in support of the cycad hypothesis for Lytico--Bodig, the Guamanian amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC), based on a new understanding of Chamorro food practices, a cyanobacterial origin of beta-methylaminoalanine (BMAA) in cycad tissue, and a possible mechanism of biomagnification of this neurotoxic amino acid in the food chain. BMAA is one of two cycad chemicals with known neurotoxic properties (the other is cycasin, a proven developmental neurotoxin) among the many substances that exist in these highly poisonous plants, the seeds of which are used by Chamorros for food and medicine. The traditional diet includes the fruit bat, a species that feeds on cycad seed components and reportedly bioaccumulates BMAA. Plant and animal proteins provide a previously unrecognized reservoir for the slow release of this toxin. BMAA is reported in the brain tissue of Guam patients and early data suggest that some Northern American patients dying of Alzheimer's disease (AD) have detectable brain levels of BMAA. The possible role of cyanobacterial toxicity in sporadic neurodegenerative disease is therefore worthy of consideration. Recent neuropathology studies of ALS/PDC confirm understanding of this disorder as a 'tangle' disease, based on variable anatomical burden, and showing biochemical characteristics of 'AD-like' combined 3R and 4R tau species. This model mirrors the emerging view that other neurodegenerative disease spectra comprise clusters of related syndromes, owing to common molecular pathology, with variable anatomical distribution in the nervous system giving rise to different clinical phenotypes. Evidence for 'ubiquitin-only' inclusions in ALS/PDC is weak. Similarly, although there is evidence for alpha-synucleinopathy in ALS/PDC, the parkinsonian component of the disease is not caused by Lewy body disease. The spectrum of sporadic AD includes involvement of the substantia nigra and a high prevalence of 'incidental'alpha-synucleinopathy in sporadic AD is reported. Therefore the pathogenesis of Lytico-Bodig appears still to have most pertinence to the ongoing investigation of the pathogenesis of AD and other tauopathies.

Citing Articles

Endemic parkinsonism: clusters, biology and clinical features.

Mensikova K, Steele J, Rosales R, Colosimo C, Spencer P, Lannuzel A Nat Rev Neurol. 2023; 19(10):599-616.

PMID: 37684518 DOI: 10.1038/s41582-023-00866-3.


Longitudinal Assessment of Behaviour and Associated Bio-Markers Following Chronic Consumption of β-Sitosterol β-D-Glucoside in Rats: A Putative Model of Parkinson's Disease.

Bigelow L, Perry M, Ogilvie S, Tasker R Front Neurosci. 2022; 16:810148.

PMID: 35281495 PMC: 8907918. DOI: 10.3389/fnins.2022.810148.


Cellular and pathological heterogeneity of primary tauopathies.

Chung D, Roemer S, Petrucelli L, Dickson D Mol Neurodegener. 2021; 16(1):57.

PMID: 34425874 PMC: 8381569. DOI: 10.1186/s13024-021-00476-x.


Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer's disease features in cortical neurons.

Silva D, Candeias E, Esteves A, Magalhaes J, Ferreira I, Nunes-Costa D J Neuroinflammation. 2020; 17(1):332.

PMID: 33153477 PMC: 7643281. DOI: 10.1186/s12974-020-02004-y.


Microbial BMAA and the Pathway for Parkinson's Disease Neurodegeneration.

Nunes-Costa D, Magalhaes J, G-Fernandes M, Cardoso S, Empadinhas N Front Aging Neurosci. 2020; 12:26.

PMID: 32317956 PMC: 7019015. DOI: 10.3389/fnagi.2020.00026.